F943-1197 Screening compound: 3-[2-(morpholin-4-yl)-2-oxoethyl]-2-oxo-N-[(pyridin-2-yl)methyl]-2,3-dihydro-1,3-benzothiazole-6-sulfonamide

F943-1197 Screening compound: 3-[2-(morpholin-4-yl)-2-oxoethyl]-2-oxo-N-[(pyridin-2-yl)methyl]-2,3-dihydro-1,3-benzothiazole-6-sulfonamide
F943-1197 Screening compound: 3-[2-(morpholin-4-yl)-2-oxoethyl]-2-oxo-N-[(pyridin-2-yl)methyl]-2,3-dihydro-1,3-benzothiazole-6-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F943-1197
3-[2-(morpholin-4-yl)-2-oxoethyl]-2-oxo-N-[(pyridin-2-yl)methyl]-2,3-dihydro-1,3-benzothiazole-6-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F943-1197

Molecular Formula

C19H20N4O5S2 (C19 H20 N4 O5 S2)

Compound Name

3-[2-(morpholin-4-yl)-2-oxoethyl]-2-oxo-N-[(pyridin-2-yl)methyl]-2,3-dihydro-1,3-benzothiazole-6-sulfonamide

IUPAC name

3-[2-(morpholin-4-yl)-2-oxoethyl]-2-oxo-N-[(pyridin-2-yl)methyl]-23-dihydro-13-benzothiazole-6-sulfonamide

SMILES

O=C(CN(c(ccc(S(NCc1ncccc1)(=O)=O)c1)c1S1)C1=O)N1CCOCC1

InChI

InChI=1S/C19H20N4O5S2/c24-18(22-7-9-28-10-8-22)13-23-16-5-4-15(11-17(16)29-19(23)25)30(26,27)21-12-14-3-1-2-6-20-14/h1-6,11,21H,7-10,12-13H2

InChI Key

JPEFFRCCYSTJNC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27205223

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.52

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.960

Distribution Coefficient, logD

0.954

Water Solubility, LogSw

-2.56

Polar Surface Area

91.414

Acid Dissociation Constant (pKa)

9.94

Base Dissociation Constant (pKb)

5.44

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.60

F943-1197 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with F943-1197 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F943-1197?
Check Price and Availability of F943-1197, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F943-1197 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F943-1197
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F943-1197
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F943-1197 available by request